Articles & Whitepapers
Australian researchers have recently solved a multi-year mystery about Parkinson's disease. They solved the structure of a key protein that is expected to rapidly treat this incurable disease. The findings appear in Nature. For the first time, the researchers took a "live" shot of a protein called PINK1. The findings explain how this protein is activated in cells, thereby initiating the ...
A medical exoskeleton is intended to help the health-challenged people. It is a dedicated biomechanical device for rehabilitation in case of lost or restricted mobility of limbs. Its operating ...
BrainScope Launches Next-Gen Medical Device: First and only FDA-cleared system for true point-of-care assessment of both concussion and brain bleeds now includes Concussion Index
BrainScope today announced the availability of its third groundbreaking FDA-cleared algorithm on the BrainScope device. The Concussion Index is the first physiological marker of concussive injury that aids clinicians in the objective assessment of ...
Neuropathix, Inc. Announces Publication of PCT Patent Application for the Treatment of Radiation Dermatitis and Other Skin Disorders
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson`s Disease
BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson`s Disease
Equipment & Solutions
At Nexstim we are using our decades of scientific research to help treat and diagnose the human brain noninvasively. As the world’s leading company combining TMS with 3D brain imaging, we offer unsurpassed technology solutions for the drug-free treatment of brain diseases and disorders. We help the human brain heal itself.